Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Treu Jesse I
Relationship:   Director
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   24    
Direct Shares   55,258    

Indirect Shares

  2,983,502      
Direct Value   $34,431    

Indirect Value

  $10,546,567      
Total Shares   3,038,760      
Total Value   $10,580,997      


Northstar Neuroscience Inc
 $0 Volcano Corp
 $0 Orexigen Therapeutics, Inc.
 $80 Veracyte, Inc.
 $34,351 Northstar Neuroscience Inc
 $0 Volcano Corp
 $0 Orexigen Therapeutics, Inc.
 $80 Veracyte, Inc.
 $34,351
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    0    

     Stock price went up :

    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Nuvasive Inc NUVA 10% Owner 0 2004-05-18 31,204    Premium*  
            Senomyx Inc SNMX 10% Owner 0 2004-06-25 19,603    Premium*  
            Santarus Inc SNTS 10% Owner 2004-04-06 0 2004-04-06 64,471    Premium*  
            Somaxon Pharmaceuticals, Inc. SOMX Director 2010-06-09 0 2009-12-18 0    Premium*  
            Vanda Pharmaceuticals Inc. VNDA 10% Owner 2006-04-18 0 2006-12-12 21,068    Premium*  
            Northstar Neuroscience Inc NSTR Director 2007-05-18 17,231 2007-05-18 14,690    Premium*  
            Paratek Pharmaceuticals Inc PRTK 10% Owner 2006-05-15 0 2009-01-30 67,875    Premium*  
            Volcano Corp VOLC 10% Owner 2008-04-24 21,289 2008-07-16 62,513    Premium*  
            Cadence Pharmaceuticals Inc CADX 10% Owner 0 2014-03-19 0    Premium*  
            Orexigen Therapeutics, Inc. OREX 10% Owner 2007-11-27 15,096 2011-12-22 50,643    Premium*  
            Alimera Sciences Inc ALIM 10% Owner 2010-04-27 0 2011-06-02 40,790    Premium*  
            Achillion Pharmaceuticals Inc ACHN 10% Owner 0 2013-01-18 244,057    Premium*  
            Zogenix, Inc. ZGNX 10% Owner 2010-11-29 0 2011-09-16 169,251    Premium*  
            Clovis Oncology, Inc. CLVS 10% Owner 2011-11-21 0 2011-11-21 51,013    Premium*  
            Durata Therapeutics, Inc. DRTX 10% Owner 0 2012-07-24 22,306    Premium*  
            Esperion Therapeutics, Inc. ESPR 10% Owner 0 2013-07-01 35,253    Premium*  
            Ocera Therapeutics Inc OCRX 10% Owner 2013-07-15 0 2013-07-15 1,920,730    Premium*  
            Tobira Therapeutics Inc TBRA Director, 10% Owner 0 2013-08-27 32,091    Premium*  
            Evoke Pharma Inc EVOK 10% Owner 0 2013-09-30 24,256    Premium*  
            Veracyte, Inc. VCYT Director 2019-03-04 1,642 2019-03-04 1,641    Premium*  
            Tandem Diabetes Care Inc TNDM Director, 10% Owner 2013-11-19 0 2013-11-19 54,390    Premium*  
            Dicerna Pharmaceuticals Inc DRNA 10% Owner 2014-02-04 0 2014-02-04 13,004    Premium*  
            Achaogen Inc AKAO 10% Owner 2014-03-17 0 2014-03-17 33,890    Premium*  
            Aldeyra Therapeutics, Inc. ALDX Director 2019-03-26 0 2019-03-26 8,763    Premium*  
* Premium Members only  

Records found :    157         Free Registration Required For Full Results.    Limit: 25

Download
  Page 1 of 7
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
SNTS Santarus Inc 10% Owner   –       –       •   2004-04-06 4 A $0.00 $0 I/I 2,793,668 64,471 -
NUVA Nuvasive Inc 10% Owner   –       –       •   2004-05-12 3 IO $0.00 $0 I/I 0 8,000 -
NUVA Nuvasive Inc 10% Owner   –       –       •   2004-05-18 4 A $0.00 $0 I/I 1,657,444 31,204 -
NUVA Nuvasive Inc 10% Owner   –       –       •   2004-05-18 4 D $11.00 $83,633 I/I (7,603) 1,744,013 -
NUVA Nuvasive Inc 10% Owner   –       –       •   2004-05-18 4 OE $0.63 $83,636 I/I 133,818 1,751,616 -
SNMX Senomyx Inc 10% Owner   –       –       •   2004-06-17 3 IO $0.00 $0 I/I 0 61,195 -
SNMX Senomyx Inc 10% Owner   –       –       •   2004-06-21 3/A IO $0.00 $0 I/I 0 61,195 -
SNMX Senomyx Inc 10% Owner   –       –       •   2004-06-25 4 A $0.00 $0 I/I 1,490,870 19,603 -
VNDA Vanda Pharmaceuticals Inc... 10% Owner   –       –       •   2006-04-18 4 A $0.00 $0 I/I 3,203,594 33,968 -
PRTK Paratek Pharmaceuticals I... 10% Owner   –       –       •   2006-05-09 3 IO $0.00 $0 I/I 0 157,497 -
PRTK Paratek Pharmaceuticals I... 10% Owner   –       –       •   2006-05-15 4 A $0.00 $0 I/I 3,731,218 87,424 -
PRTK Paratek Pharmaceuticals I... 10% Owner   –       –       •   2006-05-15 4 B $6.50 $2,999,997 I/I 461,538 98,075 1.5 -
VOLC Volcano Corp 10% Owner   –       –       •   2006-06-20 4 A $0.00 $0 I/I 9,750,411 132,732 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2006-10-24 3 IO $0.00 $0 I/I 0 27,500 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2006-10-30 4 A $0.00 $0 I/I 5,713,622 60,584 0 -
VNDA Vanda Pharmaceuticals Inc... 10% Owner   –       –       •   2006-11-03 4 A $0.00 $0 I/I 10,675 10,675 0 -
VNDA Vanda Pharmaceuticals Inc... 10% Owner   –       –       •   2006-11-03 4 D $0.00 $0 I/I (634,000) 2,535,626 0 -
VOLC Volcano Corp 10% Owner   –       –       •   2006-12-06 4 S $16.75 $25,263,171 I/I (1,508,249) 112,200 0 -
VOLC Volcano Corp 10% Owner   –       –       •   2006-12-06 4/A S $16.75 $25,263,154 I/I (1,508,248) 112,200 0 -
VNDA Vanda Pharmaceuticals Inc... 10% Owner   –       –       •   2006-12-12 4 S $25.62 $330,498 I/I (12,900) 21,068 0 -
VNDA Vanda Pharmaceuticals Inc... 10% Owner   –       –       •   2006-12-12 4 D $0.00 $0 I/I (581,176) 1,954,450 0 -
VNDA Vanda Pharmaceuticals Inc... 10% Owner   –       –       •   2006-12-12 4 A $0.00 $0 I/I 9,783 20,458 0 -
OREX Orexigen Therapeutics, In... 10% Owner   –       –       •   2007-04-25 3 IO $0.00 $0 I/I 0 260,000 -
OREX Orexigen Therapeutics, In... 10% Owner   –       –       •   2007-05-01 4 B $12.00 $6,300,000 I/I 525,000 104,975 1.5 -
OREX Orexigen Therapeutics, In... 10% Owner   –       –       •   2007-05-01 4 A $0.00 $0 I/I 3,763,807 92,859 0 -

  157  Records found
  1  2   3   4   5   6   7      
  Page 1 of 7  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed